Published in

Elsevier, The Lancet Oncology, 7(17), p. 928-942, 2016

DOI: 10.1016/s1470-2045(16)30051-1

Links

Tools

Export citation

Search in Google Scholar

First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial

Journal article published in 2016 by Barbara Eichhorst, Anna-Maria Fink, Jasmin Bahlo, Raymonde Busch, Gabor Kovacs, Christian Maurer, Elisabeth Lange, Hubert Köppler, Ursula Vehling-Kaiser, Michael Kiehl, Rudolf Schlag, Martin Sökler, Georg Köchling, Marek Trneny ORCID, Christoph Plöger and other authors.
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO